Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer

OBJECTIVE: Although targeted approaches have become available in second‐ and third‐line settings, platinum‐based chemotherapy remains the standard first‐line treatment for advanced muscle‐invasive bladder cancer (MIBC). Therefore, the prediction of platinum resistance is of utmost clinical importanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Olah, Csilla, Reis, Henning, Hoffmann, Michèle J., Mairinger, Fabian, Ting, Saskia, Hadaschik, Boris, Krafft, Ulrich, Grünwald, Viktor, Nyirady, Peter, Varadi, Melinda, Győrffy, Balázs, Kiss, Andras, Szekely, Eszter, Sjödahl, Gottfrid, Szarvas, Tibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028049/
https://www.ncbi.nlm.nih.gov/pubmed/36204983
http://dx.doi.org/10.1002/cam4.5324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028049/
https://www.ncbi.nlm.nih.gov/pubmed/36204983
http://dx.doi.org/10.1002/cam4.5324

Ejemplares similares